Deputy Minister Ling Ji of the Ministry of Commerce chaired a roundtable meeting of foreign-funded enterprises in the pharmaceutical industry, where more than 50 multinational pharmaceutical companies attended and held on-site exchanges with multiple ministries. Ling Ji said that the 15th Five-Year Plan period is a critical time for the Healthy China initiative. China’s pharmaceutical innovation ecosystem is well-established, and its medical security system is globally leading. This will bring major opportunities for multinational pharmaceutical companies to develop in China. The government adheres to a people-centered approach, improves the quality of medical products and services, strengthens pricing and regulation, and expands opening-up. It will, in accordance with the law, ensure national treatment for foreign-funded enterprises, and welcomes foreign pharmaceutical companies to further cultivate China’s market and share in the dividends of development.

K-LinePoet

2026-05-26 04:42:54

Abstract generation in progress

On May 22, Ling Ji, Vice Minister of Commerce and Deputy Representative for International Trade Negotiations, presided over a roundtable meeting with foreign-invested enterprises in the pharmaceutical sector. Representatives from more than 50 foreign enterprises, including Sanofi, Novartis, Merck & Co., Becton Dickinson, Gilead Sciences, Eli Lilly, and Danaher, attended the meeting. Relevant officials from the Ministry of Commerce, the Ministry of Industry and Information Technology, the National Health Commission, the National Healthcare Security Administration, and the National Medical Products Administration attended and exchanged with the companies on site. Ling Ji said, “The ‘15th Five-Year Plan’ period is a critical time for advancing the Healthy China initiative. China’s pharmaceutical industry has a well-developed innovation ecosystem, and it has the world’s largest healthcare service and protection system, which will create tremendous opportunities for multinational pharmaceutical companies to develop in China in the long term. The Chinese government adheres to a people-centered approach, continuously improves the quality of medical products and services, strengthens the pricing formation mechanism and regulatory system, expands opening-up in related fields, and lawfully ensures national treatment for foreign-invested enterprises. We welcome pharmaceutical companies from all countries to continue to deepen their efforts in the Chinese market and share in the dividends of China’s development.” (Ministry of Commerce)

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

Reward
like
Comment
Repost
Share

Comment

Add a comment

No comments

Trending Topics
View More
#
StockTradingChallengeUpTo17000U
16.23M Popularity
#
TrumpBacksCFTCAuthorityOverPredictionMarkets
819.86K Popularity
#
GatePredictionMarketAddsSmartMoneyTracking
13.21M Popularity
#
MicronMarketCapBreaks1Trillion
38.04K Popularity
#
TradeCFDWinGold
3.08M Popularity

Pinned

Sitemap

The Ministry of Commerce Holds Roundtable Meeting with Foreign-Funded Pharmaceutical Companies

Trending Topics

StockTradingChallengeUpTo17000U

TrumpBacksCFTCAuthorityOverPredictionMarkets

GatePredictionMarketAddsSmartMoneyTracking

MicronMarketCapBreaks1Trillion

TradeCFDWinGold

Pinned